EC
MRNS

EntryPoint Capital’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

EntryPoint Capital’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,574
Closed -$50.4K – 1765
2024
Q1 		$50.4K Buy
+5,574
New +$50.4K 0.05% 761